United States· US:17156-235_44cadee9-19ca-4756-ab85-0836b38db89f
AdreView
A medicinal product containing iobenguane i-123, registered in United States by Medi-Physics Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- IOBENGUANE I-123
- Manufacturer
- Medi-Physics Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1117156235011 VIAL, GLASS in 1 CONTAINER (17156-235-01) / 5 mL in 1 VIAL, GLASS
- ndc1117156-235-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Iobenguane i-123 in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandAdreView Iobenguane (I-123)
- United KingdomAdreView [I-123] 111MBq/1.5ml solution for injection vialsGE Healthcare Ltd
- BelgiumAdreview 74 MBq/mlGE Healthcare
- NetherlandsAdreView, Iobenguane (123I) Injection, oplossing voor injectie 74 MBq/mlGE Healthcare B.V.
- GermanyAdreviewGe Healthcare Buchler Gmbh & Co. Kg
- PolandMetajodobenzyloguanidyna- 123 I (MIBG-123 I)Narodowe Centrum Badań Jądrowych
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Belgium · Adreview, Mibg (123i)
- Czechia · Mibg (I123) Curium Netherlands
- Germany · Adreview
- Denmark · Adreview, Mibg (123i) Curium Netherlands
- Spain · Adreview, Mibg (123i) Curium Pharma Spain
- France · Adreview (123i), Mibg (123i) Curium Netherlands
- United Kingdom (Northern Ireland) · Adreview, Mibg (123i) Curium Netherlands
- Hungary · [123i]-Mibg, [123i]-Mibg Curium Netherlands
- Ireland · Mibg (123i) Curium Netherlands
- Italy · [123i]-Mibg, Adreview
- Luxembourg · Adreview
- Netherlands · Adreview, Mibg (I123) Jobenguaan Curium Netherlands
- Norway · Adreview
- Slovakia · 123i Mibg Inj
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3bbc9c4c-56cf-4839-851f-feb8b57bbe8f GET /v1/drugs/3bbc9c4c-56cf-4839-851f-feb8b57bbe8f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "2",
"substance": "IOBENGUANE I-123",
"productndc": "17156-235",
"dosage_form": "INJECTION",
"dea_schedule": null,
"strength_unit": "mCi/mL",
"application_number": "NDA022290",
"marketing_category": "NDA"
}See everything about iobenguane i-123.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.